Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors

Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that Paula Brown Stafford has been appointed to the Company’s Board of Directors, effective immediately. Ms. Stafford joined Novan in March of this year and will continue as the Chief Development Officer, leading clinical development with a focus on the execution of clinical trials, the further development of clinical operations and the establishment of medical, statistical and data management functions for Novan.